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he adapter protein tumor necrosis factor receptor
(TNFR)1–associated death domain (TRADD) plays an
essential role in recruiting signaling molecules to the
TNFRI receptor complex at the cell membrane. Here we
show that TRADD contains a nuclear export and import
sequence that allow shuttling between the nucleus and the
cytoplasm. In the absence of export, TRADD is found within
nuclear structures that are associated with promyelocytic
leukemia protein (PML) nuclear bodies. In these structures,
the TRADD death domain (TRADD-DD) can activate an
apoptosis pathway that is mechanistically distinct from its
T
 
action at the membrane-bound TNFR1 complex. Apoptosis
by nuclear TRADD-DD is promyelocytic leukemia protein
dependent, involves p53, and is inhibited by Bcl-xL but
not by caspase inhibitors or dominant negative FADD
(FADD-DN). Conversely, apoptosis induced by TRADD in
the cytoplasm is resistant to Bcl-xL, but sensitive to caspase
inhibitors and FADD-DN. These data indicate that nucleo-
cytoplasmic shuttling of TRADD leads to the activation
of distinct apoptosis mechanisms that connect the death
receptor apparatus to nuclear events.
 
Introduction
 
Tumor necrosis factor (TNF)*-
 
 
 
 regulates inflammation,
survival, proliferation, and apoptosis by activating the mem-
brane-bound receptors, TNF receptors (TNFRs)1 and 2 (for
a review of TNF family signaling see Ashkenazi and Dixit,
1998; Locksley et al., 2001). The adapter protein TNFR1-
associated death domain (TRADD) is an essential component
of the TNFR1 complex (Hsu et al.
 
,
 
 1995), and functions by
recruiting other members of the complex to the receptor.
Among these are TRAF-2, which binds the NH
 
2
 
-terminal
domain portion of TRADD (Hsu et al.
 
,
 
 1996b), and Fas-
associated death domain protein (FADD) and receptor-
interacting protein (RIP), which binds to its COOH-terminal
death domain (DD) (Hsu et al.
 
,
 
 1996a, 1996b).
FADD contains a death effector domain (DED) that
binds the DED of caspase-8. Recruitment of this caspase
through TRADD and FADD results in caspase activation
and subsequent apoptosis (Chinnaiyan et al., 1996; Hsu et
al.
 
,
 
 1996b). RIP is required for activation of NF-
 
 
 
B, which
results in the transcription of antiapoptotic genes, whereas
TRAF-2 is required for initiation of the JNK signaling path-
way (Yeh et al.
 
,
 
 1997; Kelliher et al.
 
,
 
 1998). In addition,
TRAF-2 may recruit inhibitor of apoptosis proteins (IAPs)
to the complex, resulting in inhibition of apoptosis (Shu et
al.
 
,
 
 1996). RIP is also thought to recruit RAIDD, which has
a caspase recruitment domain (CARD) that binds caspase-2,
and may thus initiate apoptosis though activation of this
caspase (Duan and Dixit
 
,
 
 1997). A product generated by
caspase-8 cleavage of RIP seems to stabilize the TRADD–
FADD interaction, resulting in further caspase-8 activation
(Lin et al.
 
,
 
 1999).
Thus, a delicate balance is maintained between pro- and
antiapoptotic signals that depend on TRADD binding to
TNFR1 at the membrane-bound death-inducing signaling
complex (DISC). The result of receptor activation (cell sur-
vival or death) is dependent on the context of its activation.
In some cases, inhibition of caspases fails to block, and may
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even increase, TNF-induced cell death. However, necrotic
rather than apoptotic death occurs in some of these pro-
cesses (Vercammen et al.
 
,
 
 1998; Jones et al., 2000; Luschen
et al.
 
,
 
 2000; Denecker et al., 2001). In some cells, p53 is re-
quired for TNFRI-dependent apoptosis (Cai et al., 1997;
Ameyar et al., 1999; Rokhlin et al., 2000), but it is unclear
why a nuclear transcription factor should be required for ap-
optosis when complex formation at the receptor can directly
activate caspases.
The promyelocytic leukemia protein (PML) is a tumor
suppressor (Rego et al., 2001) found in discrete bodies in the
nucleus known as PML oncogenic domains, or PML nuclear
bodies. PML-null cells are resistant to TNF
 
 
 
 and the PML–
RAR
 
 
 
 fusion protein, which is delocalized from nuclear
bodies to nonfunctional nuclear microspeckles in acute pro-
myelocytic leukemia patients, and antagonizes Fas ligand–
and TNF
 
 
 
-induced death (Wang et al.
 
,
 
 1998). These data
suggest that functional PML (and PML nuclear bodies) is
required for death receptor–induced apoptosis. This raises
the question of how nuclear PML might be involved in ap-
optosis that is initiated at the cell membrane by cytoplasmic
proteins such as TRADD, FADD, etc. In the case of Fas,
this link may involve Daxx, which has been reported to bind
Fas in some conditions (Chang et al., 1998; Ko et al., 2001)
and be in PML nuclear bodies in other situations (Torii et
al.
 
,
 
 1999;
 
 
 
Zhong et al., 2000b). However, a protein that is at
the TNFR1 DISC and can mediate apoptosis from PML
nuclear bodies has not been identified.
Here we report that TRADD contains both nuclear ex-
port and import sequences, allowing it to shuttle through
the nucleus. Upon inhibition of nuclear export with lepto-
mycin B (LMB), TRADD accumulates in nuclear structures
that are associated with PML nuclear bodies. A fragment of
TRADD-DD that is localized exclusively to these structures
induces death through a mechanism that involves p53 and
PML. These data suggest that shuttling of TRADD between
the cytoplasm and the nucleus activates different apoptotic
mechanisms and provides a link between components of the
TNF receptor signaling machinery and the nucleus.
 
Results
 
TRADD translocation to the nucleus
 
To study the subcellular localization of TRADD in living
cells, we transfected HeLa cells with a plasmid encoding a
green fluorescent protein (GFP)–TRADD fusion protein.
GFP–TRADD was excluded from the nucleus and had a
perinuclear or a diffuse cytoplasmic distribution (Fig. 1 A,
top left) similar to what has been described previously in
fixed cells (Jones et al.
 
,
 
 1999). At higher expression levels,
GFP–TRADD accumulated in what appeared to be the pre-
viously observed death effector filaments (Siegel et al., 1998;
Guiet and Vito, 2000; Cottin et al., 2001). Expression of a
GFP–TRADD construct with an exogenous SV40-nuclear
localization signal (NLS) fused to the NH
 
2
 
 terminus of
the GFP (NLS–GFP–TRADD) failed to change the cyto-
plasmic distribution, suggesting that GFP–TRADD might
be actively exported from the nucleus. LMB binds to and
inhibits the nuclear export receptor chromosomal region
maintenance protein (CRM)1, and has been widely used to
test whether proteins are actively exported from the nucleus
(Henderson and Eleftheriou, 2000). Cells expressing either
GFP–TRADD or triple yellow fluorescent protein (YFP
 
3
 
)
proteins were followed by time-lapse video microscopy be-
fore and after LMB treatment. Although both proteins were
initially cytoplasmic, LMB treatment led to rapid accumula-
tion of GFP–TRADD, but not YFP
 
3
 
, within the nucleus
(Fig. 1 A). These data suggest that GFP–TRADD moves be-
tween the cytoplasm and the nucleus.
To test whether the endogenous protein behaved like
the GFP-tagged molecule, we stained cells with an anti-
TRADD monoclonal antibody. TRADD has previously
been shown to localize to the medial- or cis-Golgi, as well as
to the cytoplasm (Jones et al.
 
,
 
 1999). Consistent with these
previous observations, immunostaining of untreated cells re-
vealed that endogenous TRADD had a cytosolic localization
and a punctate perinuclear Golgi distribution (Fig. 1 B) that
Figure 1.  Nuclear translocation of TRADD. (A) Time-lapse fluores-
cence microscopy of HeLa cells expressing GFP–TRADD or YFP3. 
(Left) Cells 5 min before treatment; (Center and right) The same cells 
10 and 25 min after LMB treatment. (B) Immunofluorescence staining 
of endogenous TRADD in HeLa cells. (Left) Untreated cells; (Right) 
Cells treated for 8 h with LMB. (Arrows) Examples of nuclear TRADD 
localized in dots after LMB treatment. (C) Colocalization of endogenous 
TRADD (left) with GFP-PML (top middle) or GFP-HIPK2 (bottom 
middle) 6 h after LMB treatment. (Right) A merged image shows 
colocalization of the two proteins (yellow). 
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dispersed to a diffuse cytosolic pattern upon treatment with
Brefeldin A (unpublished data). LMB treatment resulted in
the accumulation of endogenous TRADD in the nucleus,
where it formed dot-like structures in many cells (Fig. 1 B).
We investigated whether endogenous TRADD would
colocalize with PML, which is found in subnuclear domains
known as PML oncogenic domains or PML-nuclear bodies
(for review see Maul et al., 2000; Zhong et al.
 
,
 
 2000a).
Upon expression of GFP-PML in LMB-treated cells, a clear
correlation could be detected between the nuclear TRADD
structures and GFP-PML. Where present in the same nu-
clei, the two proteins appeared to be partially colocalized or
in structures juxtaposed to each other (Fig. 1 C, top).
A second protein that localizes to nuclear dots is HIPK2,
which has been reported to bind to TRADD (Li et al.
 
,
 
2000). A related protein, HIPK3, binds both FAS and
FADD and colocalizes with PML (Rochat-Steiner et al.
 
,
 
2000). HIPK2 colocalizes with PML and activates p53-
dependent apoptosis in nuclear bodies (D’Orazi et al.,
2002). Like GFP-PML, nuclear dots containing HIPK2-
GFP colocalized with, or were adjacent to, nuclear dots con-
taining endogenous TRADD in LMB-treated cells (Fig. 1
C, bottom).
 
TRADD contains a nuclear export sequence
 
Rapid nuclear accumulation of endogenous TRADD and
GFP–TRADD in LMB treated cells suggests that TRADD
contains a nuclear export sequence (NES) that is dependent
on CRM1, or binds to another protein that contains a
CRM1-dependent NES. To map this region, combinations
of NH
 
2
 
- and COOH-terminal deletions of TRADD were
created as COOH-terminal fusion proteins to GFP in the
presence or absence of an exogenous SV40-NLS to target
the molecule to the nucleus (Fig. 2 B, left). A fragment con-
taining amino acids (aa) 104–168 was sufficient to overcome
the exogenous SV40-NLS and target fusion constructs to
Figure 2.  Mapping of an NES in 
TRADD. (A) Fluorescence microscopy 
of cells expressing GFP or YFP fusion 
proteins (left). (Middle) Cell nuclei 
stained with Hoechst dye; (Right) The 
respective merged images. YFP fusion 
proteins in the top three panels contain 
an exogenous SV40 NLS. Bars, 10 mM. 
(B) Schematic diagram of NH2- and 
COOH-terminal deletions of TRADD 
expressed as COOH-terminal GFP 
fusion proteins (left). The table indicates 
whether fusion proteins were primarily 
nuclear or cytoplasmic in the presence 
or absence of an exogenous SV40-NLS 
fused to the NH2 terminus of GFP. 
(Bottom) Overlapping 20-aa segments of 
TRADD. The ability of these sequences 
to export GFP or NLS-GFP is indicated 
to the right. The TRADD NES sequence 
is shown in alignment with other known 
NES sequences (right). 
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the cytoplasm. Conversely, constructs that lacked this region
were primarily localized to the nucleus when an NLS was
present. To more precisely map the NES, we expressed over-
lapping 20-aa segments of this region as COOH-terminal
YFP fusion proteins (Fig. 2 B, bottom). Proteins containing
aa 144–163 or 154–173 were excluded from the nucleus, in-
dicating that the overlapping aa 154–163 could function as
an NES. YFP fusion proteins of these two fragments were
absent from the nucleus even when an SV40-NLS was fused
to the NH
 
2
 
 terminus of the YFP (Fig. 2 A), and relocated to
the nucleus in LMB-treated cells (unpublished data). The
solved solution structure of TRADD indicates that these 10
aa are part of an exposed alpha helix (Tsao et al., 2000). This
sequence displays homology to other NESs (Henderson and
Eleftheriou, 2000), with three of four leucines being con-
served (Fig. 2 B, right). The combination of L155A and
L162A mutations in the wild-type GFP–TRADD abolished
nuclear export, and resulted in nuclear accumulation (Fig. 2
A). These data indicated that aa 154–163 function as a
CRM1-dependent NES.
 
TRADD contains a nuclear import sequence
 
The accumulation of nuclear GFP–TRADD in LMB-
treated cells and in the L155A/L162A mutant suggests that
TRADD has a nuclear import signal. Consistent with this
hypothesis, we found that a YFP fusion protein containing
the core helices of the DD (aa 222–289) of TRADD (YFP–
TRADD-DD) was exclusively nuclear and localized in dots
(Fig. 3 A). This localization pattern in nuclear dots appears
to be specific for the TRADD-DD, as expression of the
DDs of FADD and death-associated protein kinase (DAPK)
in similar YFP fusion proteins resulted in diffuse localization
patterns similar to YFP alone.
To further define the sequence important for nuclear lo-
calization, we made NH
 
2
 
- and COOH-terminal trunca-
tions of the YFP–TRADD-DD construct. A construct con-
taining TRADD aa 222–245 was sufficient to retain YFP in
the nucleus in a pattern similar to YFP fused with an SV40-
NLS (Fig. 3 A). This region contains a stretch of several ba-
sic aa, and loosely matches the consensus for a bipartite
NLS. To verify that the putative NLS region was responsi-
ble for nuclear import, we fused the TRADD-DD to a
YFP
 
3
 
 construct. YFP
 
3
 
 is normally excluded from the nu-
cleus because it is too large to diffuse through nuclear pores
(Fig. 3 B). The resulting construct (YFP
 
3
 
–TRADD-DD)
was imported into the nucleus where it accumulated in sub-
nuclear dots (Fig. 3 B). Individual mutations in four basic
residues in this region (K229M, R231L, K232M, and
R242A) increased the cytoplasmic distribution of the
protein (unpublished data), and a triple point mutant
(K229M/R231L/K232M) resulted in a protein that was
completely excluded from the nucleus (Fig. 3 B), indicating
that this region is a functional NLS.
The previously used anti-TRADD antibody failed to rec-
ognize YFP-or GFP–TRADD-DD. Therefore, we used this
antibody to determine whether the nuclear DD colocalized
with endogenous TRADD in LMB-treated cells. A strong
colocalization was observed between GFP–TRADD-DD
and endogenous TRADD in treated cells (Fig. 3 C), suggest-
ing that the nuclear structures are identical.
 
A COOH-terminal element of TRADD regulates the 
kinetics of nuclear import
 
A recent report suggested that the COOH-terminal portion
of the TRADD-DD (aa 245–312) may associate with acidic
keratins 14 and 18, localizing TRADD to cytoplasmic fila-
ments and decreasing sensitivity to TNF (Inada et al.,
2001). We noticed that some TRADD constructs lacking
the NES accumulated in the nucleus in some cells, and in
cytoplasmic filaments in other cells. It is presently unclear
whether these cytoplasmic filaments occur under physiologi-
cal conditions, as we have observed them only at higher ex-
pression levels. Nuclear accumulation of TRADD occurred
at slower rates for constructs where these filaments were
present, and appeared to be dependent on the COOH-ter-
minal 23 aa. Therefore, we compared the cellular localiza-
tion of TRADD-DD constructs that differ only in the
COOH terminus. As shown in Fig. 4, YFP constructs con-
Figure 3.  Mapping of a nuclear localization sequence in TRADD. 
(A and B) Fluorescence microscopy of cells expressing YFP (A) or 
YFP3 (B) fusion proteins (left) as labeled. (Middle) Cell nuclei stained 
with Hoechst dye; (Rright) The respective merged images. (C) The 
merged image (right) shows colocalization of endogenous TRADD 
(left, red) and GFP–TRADD-DD (middle, green) after 6 h LMB 
treatment. Bars, 10 mM. 
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taining aa 196–289 or 222–289 were exclusively nuclear,
whereas constructs containing aa 196–312 or 222–312 had
significant cytoplasmic distribution at 24 h after transfec-
tion. These data suggest that the COOH-terminal aa con-
tain an element that regulates the kinetics of nuclear ac-
cumulation of TRADD, perhaps by inhibiting the NLS,
functioning as another NES, or binding to cytoplasmic pro-
teins such as cytokeratins. Accordingly, for experiments
to address the function of TRADD-DD in the nucleus,
we used the minimal YFP-tagged DD construct (YFP–
TRADD-DD) consisting of aa 222–289, which localizes ex-
clusively to the nucleus in PML-associated structures.
 
Nuclear YFP–TRADD-DD induces apoptosis
 
Time-lapse microscopy indicated that YFP–TRADD-DD–
expressing cells died displaying the typical hallmarks of apop-
tosis, such as membrane blebbing and condensed nuclei (Fig.
5 A; Video 1, available at http://www.jcb.org/cgi/content/full/
jcb.200204039/DC1). Quantitative cell survival analysis of
HeLa cells expressing YFP–TRADD-DD indicated that
 
 
 
25% of these cells remained alive 24 h after microinjection
(Fig. 5 B). As controls, we injected plasmids that expressed ei-
ther YFP alone, YFP fused to an SV40-NLS, or the YFP-
tagged DDs of FADD or DAPK. None of these molecules
were significantly toxic (Fig. 5 B). These data show that the
exclusively nuclear, isolated DD of TRADD is sufficient to
induce apoptosis. Truncation of YFP–TRADD-DD to aa
222–275 or 222–266 resulted in concomitant decreases in cell
death, whereas the construct containing only aa 222–255 was
comparable to YFP-NLS (unpublished data). These data indi-
cate that the DD structure is required for apoptosis.
As previously described, constructs that contained the
COOH-terminal 23 aa of TRADD were delayed in their
nuclear localization. In addition, the longer constructs were
delayed in their ability to induce death (unpublished data),
suggesting that YFP–TRADD-DD localization to the nu-
cleus was important for its ability to kill cells. To test this
hypothesis, we mislocalized the tagged minimal DD to the
plasma membrane using the myristoylation sequence from
Src. Relocation of YFP–TRADD-DD to the cell membrane
prevented cell death, whereas nuclear YFP–TRADD-DD
was effective in killing cells (Fig. 5 C). In contrast, the full-
length wild-type GFP–TRADD, which had similarly been
modified at the NH
 
2
 
 terminus with the Src myristoylation
sequence (M-w.t.), retained the ability to induce apoptosis
(Fig. 5 C). The ability of the membrane-localized full-length
TRADD to induce apoptosis is expected because this mole-
cule should still be able recruit FADD as at the TNFR1
DISC. These data suggest that the mechanism of apoptosis
induced by the nuclear TRADD-DD molecule may be dif-
ferent from its mode of action at the TNF receptor complex.
 
YFP–TRADD-DD requires PML to induce death
 
We investigated whether PML was required for YFP–
TRADD-DD–induced death in mouse embryo fibroblast
(MEF) cells. As shown in Fig. 5 D (left), about half of the
wild-type MEF cells died in response to YFP–TRADD-DD
at 24 h, when compared with YFP-injected control cells.
However, MEF cells derived from PML knockout mice were
completely resistant to YFP–TRADD-DD when compared
with control cells, indicating that PML is required for the
death signaling by nuclear YFP–TRADD-DD (Fig. 5 D,
left). As a control, an expression plasmid for wild-type
FADD was injected into PML-deficient and wild-type
MEFs. There was no difference in the sensitivity of PML
knockout cells to FADD compared with wild-type cells.
This suggests that FADD-dependent caspase activation
pathways are intact in PML 
 
 
 
/
 
 
 
 MEFs, and that the PML-
dependent signal generated by TRADD-DD is likely inde-
pendent of FADD recruitment. To verify the requirement
for PML, we coexpressed PML with TRADD-DD or YFP
in PML 
 
 
 
/
 
 
 
 MEFs. Injection of TRADD-DD or PML
alone in conjunction with YFP or control vector failed to kill
cells at this time point (Fig. 5 D, right). However, 
 
 
 
1/2 of
the cells injected with both TRADD-DD and PML died af-
ter 24 h. These data suggest that PML plays an essential role
in a nuclear apoptotic pathway induced by TRADD.
 
Expression of p53 in p53-null cells sensitizes them to 
YFP–TRADD-DD death
 
p53 is essential for TNF-dependent apoptosis in some cell
types (Cai et al., 1997; Ameyar et al., 1999; Rokhlin et al.,
2000). p53 has also been shown to localize in PML nuclear
bodies, where PML acts a transcriptional coactivator of p53
and regulates its activity (Fogal et al., 2000; Guo et al.,
2000). In addition, HIPK2, which binds to TRADD (Li et
al.
 
,
 
 2000) and colocalizes in nuclear dots (Fig. 1), can acti-
vate p53 (D’Orazi et al., 2002). To test whether p53 was
involved in death induced by nuclear TRADD-DD, we
performed microinjection experiments in HT7 cells, which
are a derivative of the p53-null cell line H1299. These cells
contain a p53 transgene regulated by a tetracycline-induc-
ible promoter, and express p53 in the presence, but not in
the absence, of doxycycline (Koumenis et al., 2001) (Fig. 5
E, bottom). As shown in Fig. 5 E, H7 cells failed to un-
dergo TRADD-DD–induced apoptosis in the absence of
doxycycline. However, doxycycline-induced expression of
p53 sensitized these cells to death by the TRADD-DD,
suggesting that p53 plays an important role in apoptosis in-
duced by nuclear TRADD-DD.
Figure 4.  The COOH-terminal aas of TRADD regulate the nuclear 
import signal. The histogram shows the localization of DD constructs 
with and without 23 COOH-terminal aa 24 h after transfection. Cells 
were are classified into three categories of YFP-TRADD localization: 
primarily nuclear (N   C), primarily cytoplasmic (N   C), or equally 
present in the cytoplasm and nucleus (N   C). 
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Figure 5.  Apoptosis by the nuclear TRADD-DD. (A) Time-lapse microscopy of 
cells expressing YFP–TRADD-DD. Fluorescence images merged with the phase 
contrast pictures show that cells expressing YFP–TRADD-DD (green) die an 
apoptotic death over the time course of the experiment. Bar, 10 mM (Video 1, 
available at http://www.jcb.org/cgi/content/full/jcb.200204039/DC1). (B) The 
cytotoxicity of YFP–TRADD-DD is shown compared with that of YFP, YFP 
fusions to the FADD, or DAPK DDs, or YFP–SV40-NLS. Data shown is the 
percentage of survival from five experiments (  SEM) 18–24 h after microinjection. 
(C) TRADD-DD requires nuclear localization for death induction. The figure 
shows a comparison between the cytotoxicity of YFP, GFP–TRADD wild-type 
(w.t.) or YFP–TRADD-DD (DD), or GFP–TRADD wild-type (M-w.t.) or 
YFP–TRADD-DD (M-DD) mislocalized to the cell membrane by an addition of 
the src-myristoylation sequence at the NH2 terminus of GFP or YFP. (D) Comparison 
between w.t. and PML  /  MEF cells in response to TRADD-DD and FADD 
(left). (Right) Coexpression of PML restores the sensitivity of PML  /  MEFs to 
TRADD-DD. (E) Transgenic expression of p53 (bottom) in the presence of 
Doxycycline sensitizes HT7 cells to death by TRADD-DD. Data shown is the 
percentage of survival from three experiments (  SEM).
 
TRADD induces apoptosis by different mechanisms in 
the nucleus and cytoplasm
 
The previous data suggest that nuclear TRADD-DD can
induce apoptosis via a mechanism that is different from the
current model, by which TRADD induces apoptosis at the
TNFR1. Therefore, we compared the effects of various
inhibitors on death induction by the exclusively nuclear
YFP–TRADD-DD and the nuclear-excluded wild-type 
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TRADD (unpublished data). A FADD-DN molecule lack-
ing the DED has been widely used to inhibit apoptosis in-
duced by death receptors, including TNFR1. Consistent
with the previously established role for TRADD (Hsu et al,
1996b), coexpression of a dsRED version of the FADD-
DN molecule prevented death induced by GFP–TRADD
(Fig. 6 B). However, this molecule failed to inhibit death
induced by the nuclear DD construct YFP–TRADD-DD
(Fig. 6 B). Conversely, microinjection of Bcl-xL with YFP–
TRADD-DD resulted in an almost complete inhibition
of YFP–TRADD-DD–induced death, but failed to block
apoptosis in GFP–TRADD–expressing cells (Fig. 6 C).
These results indicate that when in the nucleus, the
TRADD-DD activates an apoptosis pathway that is mech-
anistically distinct from that activated by TRADD in the
cytoplasm. In addition, lack of inhibition by dsRED–
FADD-DN on YFP–TRADD-DD implies that the iso-
lated DD does not cause death by upregulating machinery
in death receptor pathways upstream of FADD (i.e., FAS,
FASL, TNFR1, TNF
 
 
 
, etc.).
 
Discussion
 
In summary, we have shown that TRADD contains both
NES and NLS elements capable of nuclear export and im-
port, and causing the protein to shuttle between the cyto-
plasm and the nucleus. The export activity is sensitive to
LMB, implicating a CRM1-dependent export, and treatment
with LMB causes nuclear accumulation of endogenous
TRADD in dot-like structures that are associated with PML
nuclear bodies. The core portion of the TRADD-DD local-
izes exclusively to such structures even in the absence of LMB,
where it can induce apoptosis through a mechanism that is
different from TRADD’s previously defined role at the cell
membrane. This mechanism requires PML and p53, and may
involve the mitochondria because it is inhibited by Bcl-xL.
Detailed structure–function analyses have been performed
previously with the TRADD-DD (Hsu et al.
 
,
 
 1995; Park
and Baichwal, 1996). However, these studies utilized a
larger construct (aa 196–312) than our minimal DD con-
struct (aa 222–289), which lacks the inhibitory COOH-ter-
minal aas that delay nuclear localization and death. Based
on these previous studies, our YFP–TRADD-DD protein
should be unable to self associate, bind to TNF-R1, or acti-
vate NF-
 
 
 
B, consistent with our hypothesis that TRADD
acts by a different mechanism in the nucleus than at the
TNFR1 DISC.
Previous studies suggest that TRADD can use alternate
mechanisms to induce apoptosis in addition to the well-
known pathway involving FADD and caspase-8 recruitment.
For example, a significant percentage of FADD-deficient cells
die upon TRADD overexpression (Yeh et al., 1998). This in-
complete rescue implies that TRADD is able to kill cells inde-
pendent of FADD. Moreover, several studies show that cas-
pase inhibition often fails to prevent cell death associated with
TNF
 
 
 
 treatment (Vercammen et al.
 
,
 
 1998; Jones et al., 2000;
Luschen et al.
 
,
 
 2000; Denecker et al., 2001), suggesting a pos-
sible role for TRADD in caspase-independent death.
Previous studies also link TNF to apoptotic signaling in
the nucleus involving PML and p53. Consistent with our re-
sults, nuclear PML structures are essential for TNF
 
 
 
-medi-
Figure 6.  Mechanistic differences between TRADD w.t. and 
TRADD-DD death. (A–C) Survival assays showing comparisons 
between cells microinjected with YFP–TRADD-DD (DD) or GFP–
TRADD (w.t.) 18–24 h after initial expression and quantitation (2 h). 
Data shown is the percentage of survival  SEM from between five 
and ten experiments. (A) Survival comparison is shown in the 
presence of 150 mM z-VAD.fmk or DMSO alone and normalized 
to YFP or GFP. (B and C) Survival comparison after coinjection of (B) 
dsRED–FADD-DN; (C) Bcl-xL; or control expression plasmids with 
YFP–TRADD-DD (DD) or GFP–TRADD (w.t.).
 
GFP–TRADD molecule. The broad-spectrum caspase in-
hibitor z-VAD (150 
 
 
 
M) inhibited cell killing by GFP–
TRADD, but had only a modest effect on YFP–TRADD-
DD (Fig. 6 A). The baculoviral p35 protein also caused
only a modest inhibition when coexpressed with YFP– 
982 The Journal of Cell Biology 
 
|
 
 
 
Volume 157, Number 6, 2002
 
ated death (Wang et al., 1998), and PML has been linked to
both caspase-dependent and -independent death pathways
(Wang et al.
 
,
 
 1998; Quignon et al.
 
,
 
 1998). As YFP–
TRADD-DD is localized in PML-associated structures
where it can induce caspase-independent death, we hypothe-
size that nuclear shuttling of TRADD may provide a link
between nuclear PML and TNF
 
 
 
 signaling. p53 is also lo-
calized in PML-associated nuclear dots in some instances,
and is required for TNF signaling in some contexts (Cai et
al., 1997; Ameyar et al., 1999; Rokhlin et al., 2000). There-
fore, nuclear shuttling of TRADD may link the TNF recep-
tor with p53 through HIPK2 and/or PML, both of which
regulate p53-dependent transcription and apoptosis (Fogal
et al., 2000; Guo et al., 2000; Wang et al., 2001; D’Orazi et
al., 2002). We have not been able to demonstrate nuclear
translocation of TRADD upon TNF
 
 
 
 treatment. This may
be due in part to technical difficulties in studying such re-
sponses in cells that are rapidly undergoing apoptosis.
However, we cannot exclude the possibility that nuclear
TRADD functions in another pathway outside of TNF sig-
naling.
Death induced by nuclear TRADD-DD is inhibited by
Bcl-xL, suggesting that mitochondrial dysfunction occurs
in response to nuclear TRADD. Antiapoptotic members of
the Bcl-2 family can block some caspase-independent, as
well as caspase-dependent, death (Monney et al., 1998;
Okuno et al., 1998), consistent with the ability of Bcl-xL to
block the caspase-independent death seen here. Bax and
other p53 target genes lead to mitochondrial dysfunction
(Miyashita and Reed, 1995; Green and Reed, 1998; Oda et
al., 2000a, 2000b; Nakano and Vousden, 2001), and acti-
vation of the mitochondrial pathway is required for the
p53-dependent TNF toxicity seen in MCF-7 cells (Ameyar-
Zazoua et al., 2002).
In conclusion, our data suggest that rather than function-
ing solely in the cytoplasm, TRADD can shuttle through
the nucleus where it can activate a different apoptotic path-
way involving PML and p53. Therefore, the subcellular dis-
tribution of TRADD may modulate its activity and behav-
ior, adding an additional level of complexity to TRADD
signaling.
 
Materials and methods
 
Plasmid construction
 
The YFP–FADD-DN and YFP–DAPK-DD kinase expression plasmids have
been previously described (Morgan et al., 2001). The dS-RED–FADD-DN
expression construct was made by removing the YFP coding sequence at
the NH
 
2 
 
terminus of YFP–FADD-DN and replacing it with ds-RED (CLON-
TECH Laboratories, Inc.). Expression vectors for p35 and BCL-xL were ob-
tained from Invitrogen.
Human TRADD sequences encoding a core DD fragment (aa 222–289)
and full-length sequences (aa 1–312) of TRADD were subcloned inframe
into the COOH-terminal multiple cloning site of the pEGFP-C2 and
pEYFP-C1 vectors (CLONTECH Laboratories, Inc.), respectively, to give
GFP–TRADD and YFP–TRADD-DD. Restriction fragments for subcloning
of these sequences were obtained from previously constructed cloning
vectors generated by blunt-end ligation of PCR products (from a brain
cDNA library) into p-Blunt (Invitrogen). A segment of DNA encoding YFP
and a small, 15-aa linker was cloned into pEYFP-C1 upstream of the origi-
nal YFP start codon to give a YFP
 
2
 
 expression plasmid. The YFP
 
3
 
 construct
was created by subcloning a third YFP sequence downstream of the first
two in a strategy that preserved the multiple cloning site from the vector.
The DD fragment of TRADD (aa 222–297) was fused downstream of the
YFPs in the YFP
 
3
 
 construct to give YFP
 
3
 
–TRADD-DD. All point mutants
were generated by site-directed mutagenesis using the Quick-Change kit
(Stratagene).
NLS–GFP–TRADD and NLS-YFP were created by the insertion of an-
nealed DNA oligomers encoding aas (MLYPKKKRKGVEDQYK) from the
SV40-NLS upstream of the GFP or YFP start codons. This sequence was
also inserted COOH-terminal to YFP to make a COOH-terminal YFP-
NLS. Similarly, oligomers encoding the Src myristoylation sequence
(MGSSKSKPKDPSQR) were used to make M-GFP–TRADD. Annealed oli-
gomers spanning 20-aa segments of TRADD were cloned inframe down-
stream of YFP or NLS-YFP in pEYFP-c1 to create the constructs used in
mapping the NES. GFP fusion proteins with larger segments of TRADD
were created from GFP–TRADD and NLS–GFP–TRADD, giving the speci-
fied aa in the appropriate reading frames. DNA sequencing was carried out
to verify all constructs made.
 
Microinjection experiments and death assays
 
Plasmid DNA was injected into the nucleus of the cell using an Eppendorf
microinjector. Injections were performed with the denoted plasmid at a
concentration of 250 ng/mL, with the exception of MEF injections, which
were performed at 125 ng/mL. To quantitate cell death, healthy living fluo-
rescent cells were counted 1–2 h after microinjection, and the percent sur-
vival was determined after overnight incubation. Quantitative data shown
in the histograms represent the mean percent survival (
 
 
 
 SEM) from 3 or
15 separate experiments, with typically 50–200 cells per sample.
 
Cell culture and transfection
 
All cells were maintained in DME in the presence of 10% fetal bovine se-
rum. Additionally, HT7 cells were supplemented with 100 
 
 
 
g/mL Geneti-
cin to maintain the p53 transgene. Where indicated, cells were incubated
in the presence of the caspase inhibitor z-VAD-fmk (150 
 
 
 
M; Calbiochem)
or the corresponding volume of DMSO as a control. Expression of all con-
structs was by transfection or microinjection. In mapping experiments, nu-
clei of living cells were stained with Hoechst 33258 at a final concentra-
tion of 10 
 
 
 
g/mL. Where used, LMB (Sigma-Aldrich) was added to the
media at a final concentration of 10 
 
 g/mL. Transfections were performed
with FuGENE-6 reagent (Roche) according to the manufacturers’ protocols,
at a concentration of 2  g plasmid DNA/3.5-cm dish.
Immunofluorescence
For immunofluorescence experiments, cells were grown on glass cover-
slips, and where indicated, transfected or treated with LMB before perme-
abilizing/fixing in a 1:1 mixture of methanol/acetone at –20 C for 10 min.
Cells were then air dried and blocked in 1% fetal bovine serum in PBS for
10 min. Cells were then stained with a monoclonal anti-TRADD antibody
(BD Transduction Laboratories) for 45 min and rinsed three times with PBS
for 5 min. For detection, cells were incubated with a rhodamine-conju-
gated goat anti–mouse immunoglobulin G antibody (Jackson ImmunoRe-
search Laboratories) for 30 min followed by rinsing three times with PBS
for 5 min. Images were obtained with a Hamamatsu digital camera using
the Openlab 3.0 software (Improvision).
Online supplemental material
2 h after microinjection of HeLa cells with YFP–TRADD-DD, time-lapse
video microscopy was used to create Video 1 (available at http://
www.jcb.org/cgi/content/full/jcb.200204039/DC1), which represents ap-
optosis by the nuclear TRADD-DD and shows apoptotic death of HeLa cells
expressing YFP–TRADD-DD (green). Injections were performed 2 h before
the start of the video. Images were captured at 30-min intervals for 24 h.
Cells were maintained in an environmental chamber at 37 C and with 5%
CO2. Fluorescence images and phase contrast images were obtained at
half-hour intervals over 24 h with a Hamamatsu digital camera using the
Openlab 3.0 software (Improvision). Images were merged using Openlab
3.0 and exported in Quicktime format.
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